info@marketresearchfuture.com   📞 +1 (855) 661-4441(US)   📞 +44 1720 412 167(UK)   📞 +91 2269738890(APAC)

Fujifilm Invests USD 188 Million in New Cell Culture Media Manufacturing Facility

By Rashmi Phumatia , 26 December, 2022

FUJIFILM Corporation announced an investment of USD 188 million for establishing a cell culture media manufacturing facility in Research Triangle Park (RTP) of North Carolina, USA in November 2022. The new site would be operated by FUJIFILM Irvine Scientific, Inc., a subsidiary of FUJIFILM Corporation as well as a leading developer and manufacturer of advanced cell culture solutions for cell therapy manufacturing, life science research, bioproduction, and medical applications. The new facility is intended to ensure that the company’s subsidiary can cater to the rising demand of high-quality cell culture media solutions.

FUJIFILM Irvine Scientific has registered a significant growth over the past decade and the forecasted demand of cell culture media to support bioproduction and advanced therapies is anticipated to grow at a compound annual growth rate (CAGR) of 10%-12% through 2031. The company made the strategic decision of expanding their capacity by constructing manufacturing facilities in biotech centers throughout the world to meet the requirements of its customers. This strategy also assures a secure supply chain in line with a rapid and reliable product delivery through the development of extensive regional supply networks crucial for supporting cell and gene therapies.

Teiichi Goto, chief executive officer and president, representative director of FUJIFILM Corporation in an interview, stated that, “Fujifilm’s intensive investment in the life sciences field demonstrated our commitment of being the dedicated partner for the customers in the biopharmaceutical industry.” He also said, “We will continue to contribute towards the customers’ robust manufacturing process and the creation of novel therapies to make the world a healthier place with the support of the improved capabilities of our global manufacturing facilities for cell culture media.” Yutaka Yamaguchi, chief executive officer and chairman of FUJIFILM Irvine Scientific stated “Our customers require a rapid and reliable delivery of cell culture media for supporting their commercial production. The cell culture media produced at the North Carolina site will support in ensuring a steady supply of raw materials for cell & gene therapies, biologics, and other key medicines essential to human health.”

Land construction and development will be initiated in spring 2023 with facility operation beginning in the year 2025.

Composition of Mammalian Cell Culture Media

Media.jpg

Latest News

Revolution.png
Eco Driven Scale Startups Riding the Bio-Resin Revolution

In 2025, the bio-based resin sector is experiencing significant growth, driven by stringent environmental regulations and a resurgence of investor confidence. The global market is set to experience rapid market growth between 2025 and 2030, driven by…

Read More

2025.png
Fueling Change Hydrogen Projects Receive Unprecedented Support in 2025

In 2025, the momentum for hydrogen projects on a global level is radically increasing, incorporating hydrogen as a key component alongside other global energy transitions. The introduction of agile capital, regulation, and infrastructure during 2025…

Read More

2025.png
How Cobots are Replacing Conveyor Belts in SMEs Market 2025

In 2025, The “Cobots” Adoption in SMEs Market will Begin Transitioning as Small and Medium Sized Enterprises (SMEs) in Europe, Asia, and North America are cross-adopting collaborative robots (cobots) to enhance intralogistics and material handling…

Read More

IIoT-Startups-Secure-Record-Funding-in-Q2.jpg
IIoT Startups Secure Record Funding in Q2

The unprecedented funding of Industrial Internet of Things (IIoT) startups in Q2 marks a new record, indicating strong investors' confidence against the backdrop of an ongoing digital transformation. IIoT startups seem to be enjoying the animated…

Read More

How-Tesla-and-BMW-Slashed-Downtime-Using-Predictive-Maintenance.jpg
How Tesla and BMW Slashed Downtime Using Predictive Maintenance in 2025

By 2025, Tesla and BMW have adopted predictive maintenance as a way to optimize operations within the automotive industry. Both companies have established AI maintenance systems to address equipment failures which has greatly improved unplanned…

Read More

Author Pic
Rashmi Phumatia

Senior Manager